Developer docs
API playgroundTry for free, no card

Search company profiles

Bionaut Labs

Full company profile

uuid0003ub8

Namestring
Bionaut Labs
Legal namestring
Bionaut Labs
Websiteurl
bionautlabs.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Bionaut Labs is a US-based, privately held medical technology company founded in 2016 and headquartered in Los Angeles. The company develops microscale robots (microrobots) designed to navigate inside the human skull and central nervous system to deliver targeted treatments for brain and spinal cord disorders. Its core technology is a miniaturized robotic platform capable of reaching anatomical regions that are inaccessible through conventional neurosurgical or systemic drug delivery approaches, enabling precise, localized, and minimally invasive treatment of CNS diseases.

The company is in the clinical research stage and has not yet commercialized its platform. Its target customer segment is healthcare providers and research institutions specializing in neurology and neurosurgery. The anticipated commercial model involves medical device sales or treatment delivery services to hospitals and neurosurgical centers, with pricing not publicly disclosed. To date, the company has been funded entirely through venture capital, raising approximately $63.2 million in cumulative funding across multiple rounds, including a $43.2 million Series B led by Khosla Ventures in November 2022, with additional participation from Bold Capital Partners, Upfront Ventures, Compound, Revolution, Dolby Family Ventures, and others. Leadership includes CEO and co-founder Michael Shpigelmacher, co-founder Aviad Maizels, CSO Alex Kiselyov, CTO Eran Oren, VP of Neuroscience William Loudon, and SVP of Clinical Development and Medical Affairs Meeta Patnaik.

Short descriptiontext

Bionaut Labs develops microscale robots for targeted treatment of central nervous system disorders, navigating inside the human skull to deliver precise, minimally invasive therapies for brain and spinal cord diseases. The company serves healthcare providers and research institutions in the clinical research stage.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLos Angeles, United States
HQ citystring
Los Angeles
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
microscale medical robots, central nervous system treatment, neurosurgical robotics, precision drug delivery, brain-spine therapeutics
Industry2 codes
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHDAAAIAL
Robot Hardware, Actuators & Components (sensors, grippers, motors)
NAICS code3 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical and Medical Instrument Manufacturing339112
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Medical Robotics
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device/Treatment Platform
TypeOne Time License
Description

Bionaut Labs is developing a microscale robot platform for medical treatments. The company is in the clinical research stage with platform expansion underway, indicating a future commercial model likely involving medical device sales or treatment delivery services to healthcare providers.

businesswire.com
Cost components4 values
Technology or R&D, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Bionaut Labs develops microscale robots (microrobots) engineered to navigate inside the human skull and central nervous system for targeted treatment of brain and spinal cord diseases. The clinical-stage platform enables localized, minimally invasive precision delivery to anatomical regions that conventional neurosurgical approaches and systemic drug therapies cannot reach.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Bionaut Labs develops a microscale robot platform designed for medical applications within the human skull and central nervous system. The company's core offering consists of microscale robots that can be deployed inside the human body for targeted medical treatments, with a focus on neuroscience and healthcare applications for brain and spinal cord diseases.

Product and service1 record
1Microscale Robots for Central Nervous System Treatment
CategoryMedical Robotics
Description

Proprietary microscale robots designed for medical use inside the human skull and central nervous system, intended to deliver targeted treatments for central nervous system diseases including brain and spinal cord disorders. The platform targets healthcare providers and clinical research institutions.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Developer of the NeuroBlate minimally invasive robotic laser ablation system for neurosurgery. Most direct peer in minimally invasive robotic neurosurgical intervention, targeting overlapping hospital neurosurgery buyers.

TypeDirect peer
Description

Manufactures the NeuroMate stereotactic neurosurgical robot used for biopsy and electrode placement. Direct peer in robotic platforms deployed inside the skull for CNS procedures, sharing the same neurosurgical customer base.

TypeBroad incumbent
Description

Larger medical device incumbent whose ROSA Brain robotic platform assists in neurosurgical procedures. Comparable in that it sells robotic CNS intervention tools to neurosurgeons, though broader portfolio and far greater scale.

TypeBroad incumbent
Description

Established medtech incumbent offering neurosurgical planning, navigation, and robotic-assisted cranial platforms. Competes for the same neurosurgery capital budgets and overlaps in minimally invasive cranial intervention.

TypeEmerging player
Description

Developer of the Versius surgical robotic system. Comparable as a next-generation surgical robotics company targeting hospital OR buyers; addresses a different surgical specialty but validates the commercial path for robotic-assisted minimally invasive surgery.

TypeEmerging player
Description

Publicly listed surgical robotics company developing a combined robotics and VR platform for minimally invasive surgery. Comparable as a venture-backed surgical robotics developer pursuing novel miniaturized approaches to minimally invasive surgery.

TypeBroad incumbent
Description

Incumbent leader in robotic-assisted surgery with the Da Vinci platform. Relevant as the dominant reference point for commercial surgical robotics adoption curves, hospital economics, and reimbursement dynamics that Bionaut would ultimately face.

TypeEmerging player
Description

Neurotechnology company developing endovascular brain-computer interface technology. Comparable as a venture-backed company deploying novel implantable devices in the CNS vasculature, sharing similar regulatory, neuroscience, and clinical-trial challenges.

TypeEmerging player
Description

Developer of implantable brain-computer interface devices. Comparable as a high-profile venture-backed company building implantable neurotechnology, sharing the same CNS customer/regulatory landscape and capital-intensive hardware development profile.

TypeBroad incumbent
Description

Diversified medtech incumbent with spinal and cranial robotics platforms (Mazor, StealthStation). Overlaps as a buyer of neurosurgical robotic technology and a potential strategic acquirer of differentiated neurotech assets like Bionaut.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors19 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bionaut Labs

Medical Roboticsbionautlabs.com

Bionaut Labs develops microscale robots for targeted treatment of central nervous system disorders, navigating inside the human skull to deliver precise, minimally invasive therapies for brain and spinal cord diseases. The company serves healthcare providers and research institutions in the clinical research stage.

What Bionaut Labs does

Bionaut Labs is a US-based, privately held medical technology company founded in 2016 and headquartered in Los Angeles. The company develops microscale robots (microrobots) designed to navigate inside the human skull and central nervous system to deliver targeted treatments for brain and spinal cord disorders. Its core technology is a miniaturized robotic platform capable of reaching anatomical regions that are inaccessible through conventional neurosurgical or systemic drug delivery approaches, enabling precise, localized, and minimally invasive treatment of CNS diseases.

The company is in the clinical research stage and has not yet commercialized its platform. Its target customer segment is healthcare providers and research institutions specializing in neurology and neurosurgery. The anticipated commercial model involves medical device sales or treatment delivery services to hospitals and neurosurgical centers, with pricing not publicly disclosed. To date, the company has been funded entirely through venture capital, raising approximately $63.2 million in cumulative funding across multiple rounds, including a $43.2 million Series B led by Khosla Ventures in November 2022, with additional participation from Bold Capital Partners, Upfront Ventures, Compound, Revolution, Dolby Family Ventures, and others. Leadership includes CEO and co-founder Michael Shpigelmacher, co-founder Aviad Maizels, CSO Alex Kiselyov, CTO Eran Oren, VP of Neuroscience William Loudon, and SVP of Clinical Development and Medical Affairs Meeta Patnaik.

Bionaut Labs firmographics

Firmographics
Name
Bionaut Labs
Legal name
Bionaut Labs
Website
https://bionautlabs.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Bionaut Labs develops microscale robots for targeted treatment of central nervous system disorders, navigating inside the human skull to deliver precise, minimally invasive therapies for brain and spinal cord diseases. The company serves healthcare providers and research institutions in the clinical research stage.
Ownership category
akta.pro rank

Bionaut Labs industry classification

Industry
Product category
Medical Robotics
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHDAAAIAL
Robot Hardware, Actuators & Components (sensors, grippers, motors)

Keywords

  • Microscale medical robots
  • Central nervous system treatment
  • Neurosurgical robotics
  • Precision drug delivery
  • Brain-spine therapeutics

Where Bionaut Labs is headquartered

Location

Headquarters

HQ city
Los Angeles
HQ country
United States
HQ region
North America

Markets served

Bionaut Labs business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

  1. Medical Device/Treatment Platform: Bionaut Labs is developing a microscale robot platform for medical treatments. The company is in the clinical research stage with platform expansion underway, indicating a future commercial model likely involving medical device sales or treatment delivery services to healthcare providers.

Go-to-market motion1 record

Bionaut Labs product offering

Product offering

Core offering

Bionaut Labs develops microscale robots (microrobots) engineered to navigate inside the human skull and central nervous system for targeted treatment of brain and spinal cord diseases. The clinical-stage platform enables localized, minimally invasive precision delivery to anatomical regions that conventional neurosurgical approaches and systemic drug therapies cannot reach.

Product overview

Bionaut Labs develops a microscale robot platform designed for medical applications within the human skull and central nervous system. The company's core offering consists of microscale robots that can be deployed inside the human body for targeted medical treatments, with a focus on neuroscience and healthcare applications for brain and spinal cord diseases.

Differentiator

Problem solved

Functional benefit

Products and services

  • Microscale Robots for Central Nervous System Treatment Proprietary microscale robots designed for medical use inside the human skull and central nervous system, intended to deliver targeted treatments for central nervous system diseases including brain and spinal cord disorders. The platform targets healthcare providers and clinical research institutions.

Companies that use Bionaut Labs

Customer profile

Segments1 record

Ideal customer profiles1 record

Bionaut Labs technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Bionaut Labs partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Bionaut Labs competitors and assessment

Company assessment

Direct peers

  • Monteris Medical: Developer of the NeuroBlate minimally invasive robotic laser ablation system for neurosurgery. Most direct peer in minimally invasive robotic neurosurgical intervention, targeting overlapping hospital neurosurgery buyers.
  • Renishaw: Manufactures the NeuroMate stereotactic neurosurgical robot used for biopsy and electrode placement. Direct peer in robotic platforms deployed inside the skull for CNS procedures, sharing the same neurosurgical customer base.

Broad incumbents

  • Zimmer Biomet (ROSA Brain): Larger medical device incumbent whose ROSA Brain robotic platform assists in neurosurgical procedures. Comparable in that it sells robotic CNS intervention tools to neurosurgeons, though broader portfolio and far greater scale.
  • Brainlab: Established medtech incumbent offering neurosurgical planning, navigation, and robotic-assisted cranial platforms. Competes for the same neurosurgery capital budgets and overlaps in minimally invasive cranial intervention.
  • Intuitive Surgical: Incumbent leader in robotic-assisted surgery with the Da Vinci platform. Relevant as the dominant reference point for commercial surgical robotics adoption curves, hospital economics, and reimbursement dynamics that Bionaut would ultimately face.
  • Medtronic (Mazor Robotics / StealthStation): Diversified medtech incumbent with spinal and cranial robotics platforms (Mazor, StealthStation). Overlaps as a buyer of neurosurgical robotic technology and a potential strategic acquirer of differentiated neurotech assets like Bionaut.

Emerging players

  • CMR Surgical: Developer of the Versius surgical robotic system. Comparable as a next-generation surgical robotics company targeting hospital OR buyers; addresses a different surgical specialty but validates the commercial path for robotic-assisted minimally invasive surgery.
  • Vicarious Surgical: Publicly listed surgical robotics company developing a combined robotics and VR platform for minimally invasive surgery. Comparable as a venture-backed surgical robotics developer pursuing novel miniaturized approaches to minimally invasive surgery.
  • Synchron: Neurotechnology company developing endovascular brain-computer interface technology. Comparable as a venture-backed company deploying novel implantable devices in the CNS vasculature, sharing similar regulatory, neuroscience, and clinical-trial challenges.
  • Neuralink: Developer of implantable brain-computer interface devices. Comparable as a high-profile venture-backed company building implantable neurotechnology, sharing the same CNS customer/regulatory landscape and capital-intensive hardware development profile.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Bionaut Labs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bionaut Labs leadership team

Management profile

Number of profiles

Profiles6 records

Bionaut Labs funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors19 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bionaut Labs M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bionaut Labs

What does Bionaut Labs do?

Bionaut Labs develops microscale robots (microrobots) engineered to navigate inside the human skull and central nervous system for targeted treatment of brain and spinal cord diseases. The clinical-stage platform enables localized, minimally invasive precision delivery to anatomical regions that conventional neurosurgical approaches and systemic drug therapies cannot reach.

Is Bionaut Labs a public or private company?

Bionaut Labs is a private company. It is classified as venture growth investor backed and is currently operating.

When was Bionaut Labs founded?

Bionaut Labs was founded in 2016. It employs 11 to 50 people.

Where is Bionaut Labs based?

Bionaut Labs is headquartered in Los Angeles, United States, in the North America region.

How does Bionaut Labs make money?

One revenue line is on record: medical Device/Treatment Platform.

Who are Bionaut Labs's main competitors?

Direct peers on record are Monteris Medical and Renishaw. Broad incumbents are Zimmer Biomet (ROSA Brain), Brainlab, Intuitive Surgical and Medtronic (Mazor Robotics / StealthStation). Emerging players are CMR Surgical, Vicarious Surgical, Synchron and Neuralink.

Does Bionaut Labs have an API?

No public API is recorded for Bionaut Labs.

What industry is Bionaut Labs in?

Bionaut Labs's product category is Medical Robotics. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HDAAAIAL, Robot Hardware, Actuators & Components (sensors, grippers, motors). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BionautlabsPartnerships — BionautBionaut is seeking partnerships for its micro-technology platform to enable precision drug delivery and procedures in the brain. The company currently collaborates with Candel Therapeutics on delivering oncolytic viruses for malignant gliomas and the Max Planck Institute on developing its micro-robotic platform.FortuneExclusive: Bionaut Labs raises an extension round in preparation for micro-robot clinical trialsBionaut Labs raised an extension round with Mayo Clinic and existing investors, including Gates Ventures, to prepare for human clinical trials later this year. The company has raised over $70 million, with its micro-robot designed to deliver drugs to hard-to-reach brain areas. The first clinical trial will target Dandy-Walker Syndrome.YahooExclusive: Bionaut Labs raises an extension round in preparation for micro-robot clinical trialsBionaut Labs has secured an extension funding round to support upcoming human clinical trials for its magnetic micro-robot technology, which delivers drugs precisely within the brain. The investment includes participation from the Mayo Clinic and Gates Ventures, joining existing investors Khosla Ventures, Upfront Ventures, and OurCrowd. This brings the company's total capital raised to over $70 million.American City Business Journals14 L.A. startups to watch in 2023L.A. Inno's inaugural Startups to Watch list profiles 14 early-stage companies across industries like robotics, crypto, and healthcare. The startups have raised over $100 million combined, including Boulevard's $70 million Series C and Bionaut Labs' $43 million Series B. The list highlights companies poised for growth in 2023.Built In LAPearpop Raised $18M, Bionaut Labs Got $43M, and More LA Tech NewsLos Angeles tech companies raised funding in November, including Bionaut Labs' $43M Series B and Pearpop's $18M Series A. The biotech firm aims to deliver drugs via micro-robotics, while Pearpop's platform lets users buy celebrity collaborations on TikTok. Local companies collectively raised over $276 million in the five largest capital raises.FinSMEsBionaut Labs Closes $43M Series B FundingBionaut Labs raised $43M in Series B funding led by Khosla Ventures. The funds will advance clinical development of its lead programs against malignant glioma and Dandy-Walker Syndrome. The company also plans to treat Parkinson's and Huntington's disease.FierceBiotechBionaut Labs secures $43M for its tiny, drug-carrying robotsBionaut Labs secured $43.2 million in Series B venture capital funding to develop micro-scale robots capable of delivering drugs through the human body. The company, which aims to begin human trials for brain tumors and neurological disorders in 2024, was led by Khosla Ventures with participation from several other investors. These funds will support clinical development of lead programs targeting malignant glioma and Dandy-Walker syndrome.Business Wire BlogBionaut Labs Closes $43M in Series B Led by Khosla Ventures to Advance First-in-Class Micro-Robotic Technology and Remove Barriers to Treat Rare and Debilitating DiseasesBionaut Labs announced the closing of a $43.2 million Series B financing round led by Khosla Ventures to support the development of its micro-robotic technology for treating central nervous system diseases. The funds will facilitate clinical development against conditions such as malignant glioma and Dandy-Walker Syndrome, with plans for human trials to initiate in 2024. Bionaut Labs aims to innovate treatment for neurological disorders by providing localized drug delivery to previously inaccessible areas in the brain.VC News DailyBionaut Labs Closes $43M in Series BBionaut Labs, a Los Angeles-based company developing microscale robots for the treatment of central nervous system diseases and disorders, announced the closing of a $43.2 million Series B funding round. The round was led by Khosla Ventures with participation from multiple new and existing investors, bringing the company's total financing raised to date to $63.2 million. The funding will support continued development of the company's microscale robotics platform for CNS applications.Built In LABionaut Labs Secures $43M to Treat Brain Diseases With Micro-RobotsBionaut Labs secured $43 million in Series B funding to advance its remote-controlled micro-robot technology for treating brain diseases. The company plans to utilize this capital to expand clinical targets, including malignant glioma and Dandy-Walker Syndrome, while pursuing accelerated FDA designations. Bionaut Labs aims to initiate human clinical trials in 2024.